Health Services Research
Latest posts by Health Services Research (see all)
- Priorities for Patient-Centered Outcomes Research: The Views of Minority and Underserved… - May. 23, 2016
- The Contribution of Skilled Nursing Facilities to Hospitals’ Readmission Rate - May. 19, 2016
- The Effect of Physician and Hospital Market Structure on Medical Technology Diffusion - May. 17, 2016
- Hospital Surgical Volumes and Mortality after Coronary Artery Bypass Grafting: Using… - May. 17, 2016
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.